Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: A prospective study

Beaujard, 2000, Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis, Cancer, 88, 2512, 10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J Cavaliere, 2000, Treatment of peritoneal carcinomatosis with intent to cure, J Surg Oncol, 74, 41, 10.1002/1096-9098(200005)74:1<41::AID-JSO10>3.0.CO;2-R Elias, 2001, Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy, Cancer, 92, 71, 10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9 Loggie, 2000, Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin, Am Surg, 66, 561, 10.1177/000313480006600607 Shen, 2003, Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis, Arch Surg, 138, 26, 10.1001/archsurg.138.1.26 Sugarbaker, 1999, Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy, Ann Surg Oncol, 6, 727, 10.1007/s10434-999-0727-7 Kohne, 2002, Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: Results of a multivariate analysis of 3825 patients, Ann Oncol, 13, 308, 10.1093/annonc/mdf034 Isacoff, 1997, Chemotherapy for the treatment of patients with metastatic colorectal cancer: An overview, World J Surg, 21, 748, 10.1007/s002689900301 Iveson, 1999, Irinotecan in second-line treatment of metastatic colorectal cancer: Improved survival and cost-effect compared with infusional 5-FU, Eur J Cancer, 35, 1796, 10.1016/S0959-8049(99)00186-0 Jayne, 2002, Peritoneal carcinomatosis from colorectal cancer, Br J Surg, 89, 1545, 10.1046/j.1365-2168.2002.02274.x Sadeghi, 2000, Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study, Cancer, 88, 358, 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O Marcus, 1999, Prognostic factors affecting survival in patients with colorectal carcinomatosis, Cancer Invest, 17, 249, 10.3109/07357909909040593 Sticca, 2003, Peritoneal carcinomatosis: A final frontier, Ann Surg Oncol, 10, 484, 10.1245/ASO.2003.04.907 Sugarbaker, 2003, Carcinomatosis—is cure an option?, J Clin Oncol, 21, 762, 10.1200/JCO.2003.12.071 Verwaal, 2003, Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer, J Clin Oncol, 21, 3737, 10.1200/JCO.2003.04.187 Laufman, 1987, Leucovorin plus 5-fluorouracil: An effective treatment for metastatic colon cancer, J Clin Oncol, 5, 1394, 10.1200/JCO.1987.5.9.1394 Shimada, 1996, Efficacy of CPT-11 (irinotecan) as a single agent in metastatic colorectal cancer, Eur J Cancer, 32A, S13, 10.1016/0959-8049(96)00292-4 Elias, 2001, Intraperitoneal chemohyperthermia: Rationale, technique, indications, and results, Surg Oncol Clin N Am, 10, 915, 10.1016/S1055-3207(18)30039-5 Sugarbaker, 1995, Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer, World J Surg, 19, 235, 10.1007/BF00308632 Cortina, 1995, Management and prognosis of adenocarcinoma of the appendix, Dis Colon Rectum, 38, 848, 10.1007/BF02049842 Proulx, 1997, Appendiceal carcinoma: Patterns of failure following surgery and implications for adjuvant therapy, J Surg Oncol, 66, 51, 10.1002/(SICI)1096-9098(199709)66:1<51::AID-JSO10>3.0.CO;2-R Miller, 1997, Colon cancer with metastasis to the ovary at time of initial diagnosis, Gynecol Oncol, 66, 368, 10.1006/gyno.1997.4811 Taieb, 2005, Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: Results of a phase II study, J Clin Oncol, 23, 502, 10.1200/JCO.2005.05.082 Tournigand, 2004, FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study, J Clin Oncol, 22, 229, 10.1200/JCO.2004.05.113 Cunningham, 2004, Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer, N Engl J Med, 351, 337, 10.1056/NEJMoa033025 Hurwitz, 2004, Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer, Clin Colorectal Cancer, 4, S62, 10.3816/CCC.2004.s.010